Circular RNA Holds Promise as Cancer Biomarker

The stable structure of circRNA makes it an ideal candidate for biomarkers because it can be detected in blood or urine, making it potentially useful for cancer diagnosis or prognosis.

11:00 AM

Author | Nicole Fawcett

As new technology allows researchers to plunge deeper into the genome and exome, a new class of RNA called circRNA, or circular RNA, may play an intriguing role.

Researchers at the University of Michigan Rogel Cancer Center have cataloged circular RNA in multiple cancers. Their initial research suggests these stable structures could serve as cancer biomarkers in blood or urine.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Circular RNA are a type of noncoding RNA that forms into a closed circular structure rather than a linear structure. New RNA sequencing methods have brought these to light, although little is still known about why or how they function. But their stable structure makes them ideal candidates for developing cancer biomarkers.

Creating a database

The study, published in Cell, identifies a compendium of circRNA in cancer, creating a database for future study.

"I'm most excited about the potential of circular RNAs as noninvasive biomarkers," says Arul M. Chinnaiyan, M.D., Ph.D., director of the Michigan Center for Translational Pathology and S.P. Hicks Professor of Pathology at Michigan Medicine. "Because of their stability, we might be able to detect these in the blood or urine of cancer patients. This could be useful for diagnosis or prognosis of cancer."

SEE ALSO: Stressed-Out Cells Pack Away Their Most Precious RNA, Researchers Find

The team identified circRNA from more than 800 tumor samples collected as part of the MiONCOSEQ program. They demonstrated that the capture RNA sequencing developed for MiONCOSEQ was more robust in detecting circRNA than existing methods.

"The capture approach can be limited because it's based on the probes we used to capture RNAs," Chinnaiyan says. "But the whole exome capture approach makes it significant. We capture a large swath of RNA that way. That's why we were able to nominate so many circRNAs that were not known before."

Only a small amount

The technique requires only a small amount of total RNA to be able to identify circRNA. This means it could be detected in places where RNA is diluted, such as blood or urine.

In addition, the team identified several circRNAs that were found in prostate cancer tissue. By evaluating circRNA from prostate cancer cells, they found them to be more stable than linear RNA. They could also be detected in urine samples.

SEE ALSO: New Technique Improves Efficiency and Accuracy of Single-Cell RNA Sequencing

"We were able to show that these circRNAs exist in urine and that those coming from prostate cancer can be detected," Chinnaiyan says. "Our future studies will explore these circRNAs as urine- or blood-based cancer biomarkers."

The researchers turned their findings into a database called MiOncoCirc, cataloging the reported circRNAs from tumor samples. This resource is available to other researchers to aid in developing new cancer biomarkers.

More Articles About: Lab Report Basic Science and Laboratory Research Cancer Research All Research Topics
Health Lab word mark overlaying blue cells
Health Lab

This article is from the Health Lab digital publication.

Media Contact Public Relations

Department of Communication at Michigan Medicine



Get a weekly digest of medical research and innovation, straight to your inbox.

Featured News & Stories microscope cells glioma
Health Lab
Researchers circumvent radiation resistance in subtype of brain tumors
University of Michigan Rogel Cancer Center researchers find ZMYND8 gene plays a critical role in conferring radiation resistance on brain tumors with IDH1 mutation.
cell slides under microscope
Health Lab
P53 could be key to therapies for salivary gland cancer
Mouse models show that activating a non-mutated form of the gene could lead to developing therapies for this deadly form of cancer. 
Blue green cell microscopic amino
Health Lab
Dietary change starves cancer cells, overcoming treatment resistance
A new study in cells and mice from the University of Michigan Rogel Cancer Center has found that a low-protein diet and a specific reduction in amino acids can improve treatment for colon cancer.
A model demonstrating how this type of novel drug is absorbed through the lymphatic system.
Health Lab
New drug candidate uses novel absorption method to target cancer cells in mice
By using the lymphatic system as a storage reservoir, researchers found they could optimize drug concentrations to simultaneously target two molecular signaling pathways responsible for cancer growth.
liver cancer cells microscopic cells
Health Lab
Researchers identify a hormone from fat cells that reprogram the liver microenvironment and restrain tumor growth in mice
Molecular changes in nonalcoholic fatty liver disease could serve as potential therapeutic targets to halt the cells’ progression to liver cancer.
microscopic nanoparticle colorful cellular inhibitor
Health Lab
Outsmarting brain cancer
The approach, studied in mice, overcomes the blood brain barrier and breaks the shield tumors build against the immune response.